“Reality check”: In early data, AstraZeneca vaccine offers minimal protection against South African variant – Sydney Morning Herald

It remains unclear if the vaccine will still protect against serious illness and death; scientists who were part of the South African trial are hopeful it will.
The University of Oxford, which co-developed the vaccine, said it was working on a booster jab to provide protection against the variant, if necessary.
CSL, which is contracted by the government and AstraZeneca to produce 50 million doses of the vaccine at its Broadmeadows plant, did not comment directly on whether it could modify the jab…

Click here to view the original article.